+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Urokinase receptor/urokinase system in U937 cells and mature monocytes



Urokinase receptor/urokinase system in U937 cells and mature monocytes



British Journal of Haematology 102(1): 59




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144195

Download citation: RISBibTeXText


Related references

Invasion by esophageal cancer cells: Functional contribution of the urokinase plasminogen activation system, and inhibition by antisense oligonucleotides to urokinase or urokinase receptor. Clinical & Experimental Metastasis 17(1): 77-85, 1999

Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor. Journal of Biological Chemistry 269(41): 25668-25676, 1994

The Urokinase/Urokinase Receptor System in Mast Cells: Effects of its Functional Interaction with fMLF Receptors. Translational Medicine @ Unisa 15: 34-41, 2016

Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic a2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor. The Journal of Biological Chemistry 269: 668-76, 1994

Urokinase receptor expression on monocytes and plasma urokinase content are decreased in coronary artery disease. European Heart Journal 18(ABSTR Suppl. ): 631, 1997

Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits urokinase/urokinase-receptor expression and MMP-9 secretion by peripheral blood monocytes--a possible protective mechanism against atherothrombosis. Thrombosis and Haemostasis 84(4): 680-688, 2000

Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proceedings of the National Academy of Sciences of the United States of America 82(15): 4939-4943, 1985

Inhibition of the tumor-associated urokinase-type plasminogen activation system: effects of high-level synthesis of soluble urokinase receptor in ovarian and breast cancer cells in vitro and in vivo. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 162: 43-63, 2003

High-affinity urokinase-derived cyclic peptides inhibiting urokinase/urokinase receptor-interaction: Effects on tumor growth and spread. FEBS Letters 528(1-3): 212-216, 25 September, 2002

A hybrid protein of urokinase growth-factor domain and plasminogen-activator inhibitor type 2 inhibits urokinase activity and binds to the urokinase receptor. European Journal of Biochemistry 207(1): 177-183, 1992

Urokinase-related proteins in human urine. Isolation and characterization of single-chain urokinase (pro-urokinase) and urokinase-inhibitor complex. Journal of Biological Chemistry 261(3): 1267-1273, 1986

Effect of purified, soluble urokinase receptor on the plasminogen-pro-urokinase activation system. Febs Letters. 393(1): 31-36, 1996